<DOC>
	<DOCNO>NCT01821989</DOCNO>
	<brief_summary>Hypothesis : Orally ingest lactoferrin effect promotion growth differentiation immature gut ; also immunomodulatory property , prevent serious infection preterm infant . The aim study : - Evaluate effectiveness oral lactoferrin prevention neonatal sepsis . - Compare two dose regiment lactoferrin supplementation . - Study effect lactoferrin supplementation serum iron store . It prospective , randomize , double blind , placebo-controlled study , include 180 preterm neonate admit Neonatal Intensive Care Units Ain Shams University Hospitals Manshiet El Bakry Hospital . •Group A : Who receive oral lactoferrin supplementation dose 100 mg/day . •Group B : Who receive oral lactoferrin supplementation dose 150 mg/kg/ twice daily . •Group C ( Controls ) : Who match subject neonate , receive placebo form distil water .</brief_summary>
	<brief_title>Oral Lactoferrin Supplementation Prevention Sepsis Preterm Neonate</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>1 . Neonates birth weight 500g 2500g . 2 . Neonates ≤ 36 week gestation count first day Last Menstrual Period . 3 . Preterm neonate bear , refer Neonatal Intensive Care Units one participate hospital first 48 hour life . 1 . Neonates underlie gastrointestinal problem prevent oral intake . 2 . Neonates predispose condition profoundly affect growth development ( chromosomal abnormality , structural brain anomaly , severe congenital abnormality ) . 3 . Neonates family background cow milk allergy . 4 . Neonates chance complete study time ( refer another hospital ) . 5 . Neonates whose parent decline participate . 6 . Neonates early onset sepsis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>